Representing RDD Pharma in a merger with a Nasdaq traded company

Partners Ofer Ben-Yehuda, Amir Iliescu and Doron Mutai & associates Daniel Kariv, Ofer Filhaber and Roni Lifshitz represented RDD Pharma in a merger transaction of the Nasdaq traded company Innovate Biopharmaceuticals Inc.; the new name of the merged company is 9 Merers Biopharma Inc.

In addition, a third company was also acquired and 22M USD was raised in new financing that was led by Orbimed Advisors, LLC.

Read the full article

Related News